| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 02/19/2009 | US20090047339 Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof |
| 02/19/2009 | US20090047286 H2n3 influenza a viruses and methods of use |
| 02/19/2009 | US20090047255 Alphavirus and Alphavirus Replicon Particle Formulations and Methods |
| 02/19/2009 | US20090047254 Bacteriophage and their uses |
| 02/19/2009 | US20090047244 Macrocyclic serine protease inhibitors i |
| 02/18/2009 | EP0673415B1 Recombinant viral vector system |
| 02/18/2009 | CN101370936A DNA modular cloning vector plasmids and methods for their use |
| 02/18/2009 | CN100462438C Chimeric type 5/type 11 or type 35 adenovirus vector for preventing infection with antihuman immunodeficiency virus |
| 02/17/2009 | US7491525 Specific proliferation in tumour cell which can express antioncogene with high efficiency and the use of it |
| 02/17/2009 | US7491508 termini grow efficiently in desired cell line; left terminus spans the 5' inverted terminal repeat, left terminus spans the E4 region and the 3' inverted terminal repeat; internal regions does not grow efficiently in the desired cell; adenovirus vectors use for gene therapy; culturing; vaccines |
| 02/17/2009 | US7491399 introducing in ovo in poultry ovum a vaccine containing a recombinant virus comprising Segment A (SEQ ID NO: 5) modified to include nucleotide sequences from D78 and GLS strains and wherein the NS protein is not expressed, to protective against STC-IBDV |
| 02/17/2009 | US7491387 Disinfection of foodstuffs |
| 02/12/2009 | WO2009019293A1 Modified bacteriophage including an alpha/beta small acid-soluble spore protein (sasp) gene |
| 02/12/2009 | WO2009018964A2 System comprising bacteriophages and particles that contain active substances |
| 02/12/2009 | WO2008093009A3 Method for preparing bacteriophages modified by the insertion of random sequences in the screening proteins of said bacteriophages |
| 02/12/2009 | US20090042299 Vectors and methods for tissue specific synthesis of proteins in eggs of transgenic hens |
| 02/12/2009 | US20090042274 Method of Purifying Virus Envelope |
| 02/12/2009 | US20090042273 Recovery of virus from cell culture using hypertonic salt solution |
| 02/12/2009 | US20090042182 Detection of bovine viral diarrhea virus in tissue samples |
| 02/12/2009 | US20090041725 Replication-Deficient RNA Viruses as Vaccines |
| 02/12/2009 | US20090041724 Protein Delivery System |
| 02/12/2009 | CA2695939A1 Modified bacteriophage |
| 02/11/2009 | EP2022849A1 Method for proliferation of influenza virus |
| 02/11/2009 | EP1409012B1 Methods of inducing a cytotoxic immune response and recombinant simian adenovirus compositions useful therein |
| 02/11/2009 | EP1259258B1 Gm-negative ehv-mutants |
| 02/11/2009 | EP1140164B1 Multivalent immunogenic composition containing rsv subunit composition and influenza virus preparation |
| 02/11/2009 | EP0946731B1 Non-m non-o hiv strains, fragments and applications |
| 02/11/2009 | CN201192460Y Disposable light avoid type photosensitive agent storage releasing piece |
| 02/11/2009 | CN101365713A Porcine circovirus type 2 vaccines |
| 02/11/2009 | CN101365481A Canine influenza virus and related compositions and methods of use |
| 02/11/2009 | CN101363029A Lentiviral triplex dna, and vectors and recombinant cells containing lentiviral triplex DNA |
| 02/10/2009 | US7488593 Using genetic engineering to prepare virus having plurality of recognition sites for selective binding or nucleating; synthesis of trifunctionalized viral particles for use as field effect transistors |
| 02/10/2009 | US7488484 Multimeric protein fo treating and preventing viral infection; immunosuppressant |
| 02/10/2009 | CA2331368C Nucleic acid vaccines for prevention of flavivirus infection |
| 02/10/2009 | CA2198743C Feline infectious peritonitis vaccine |
| 02/10/2009 | CA2166318C Pharmaceutical compositions and their use, namely for the treatment of neurodegenerative diseases |
| 02/05/2009 | WO2008143647A3 Methods of treating viral infection |
| 02/05/2009 | US20090035838 Microfabricated Crossflow Devices and Methods |
| 02/05/2009 | US20090035837 Virus Production |
| 02/05/2009 | US20090035836 Modulating ph-sensitive binding using non-natural amino acids |
| 02/05/2009 | US20090035747 Nucleic Acid and Gene Derived from Novel HCV Strain and Replicon-Replicating Cell Using Said Gene |
| 02/05/2009 | US20090035278 Reoviruses having modified sequences |
| 02/05/2009 | US20090035276 Use of a combination of myxoma virus and rapamycin for therapeutic treatment |
| 02/05/2009 | US20090035266 Immunogenic peptides and methods of use |
| 02/05/2009 | CA2663034A1 Oncolytic rhabdovirus |
| 02/04/2009 | EP2020436A1 Method for producing adenovirus vectors for gene therapy and dna sequences used therefor |
| 02/04/2009 | EP2019863A1 High-titer retroviral packaging cells |
| 02/04/2009 | EP2019860A2 Protein production using eukaryotic cell lines |
| 02/04/2009 | CN101360823A Recombinant multivalent vaccine |
| 02/04/2009 | CN101360821A Stabilizing formulations for recombinant viruses |
| 02/04/2009 | CN101360510A Combination vaccine comprising an attenuated bovine viral diarrhea virus |
| 02/04/2009 | CN101358207A Method for preparing membrane protein based on human enveloped virus budding mode |
| 02/04/2009 | CN101358206A Separation method of cellular membrane and cellular organelle membrane protein based on budding of insect virus |
| 02/04/2009 | CN101358204A Method for preparing cellular membrane and cellular organelle membrane protein after human enveloped virus budding |
| 02/04/2009 | CN101358203A Method for preparing membrane protein based on enveloped virus budding mode of insect |
| 02/04/2009 | CN101358202A Recombinant canine adenovirus type 2 transfer vector, construction method and application thereof |
| 02/04/2009 | CN101358182A Recombinant baculovirus strain of porcine circovirus type 2 Cap protein expression, construction method and application thereof |
| 02/04/2009 | CN101357227A Senile dementia recombinant adenovirus gene vaccine and preparation method thereof |
| 02/04/2009 | CN101357226A Replication-deficient human type 3 adenovirus vaccine |
| 02/04/2009 | CN100457896C Virus in deactivated bioproduct and method of removing toxin in bacteria |
| 02/04/2009 | CN100457775C Polypeptides having brain disposition activity and utilization of the same |
| 02/03/2009 | US7485458 Expression vector comprising adenoviral regulatory sequences for use as tool in enhancement of heterologous gene transfer and viral expression in cells |
| 02/03/2009 | US7485415 Sequence analysis of the tetravalent rotavirus vaccine |
| 02/03/2009 | US7485318 Biodegradable carrier and method for preparation thereof |
| 02/03/2009 | US7485292 Administering echovirus which recognizes integrin alpha 2 beta 1 for infectivity of the cells such that at least one of the cells are killed by the virus, wherein the abnormal cell is a cancer cell expressing alpha 2 beta 1; screening viruses |
| 02/03/2009 | US7485291 Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof |
| 02/03/2009 | CA2286165C A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin |
| 01/29/2009 | WO2009014919A2 H2n3 influenza a viruses and methods of use |
| 01/29/2009 | WO2009014782A2 Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
| 01/29/2009 | WO2009014774A1 Methods and compositions for live attenuated viruses |
| 01/29/2009 | WO2009013324A1 Vector particles for targeting cd34+ cells |
| 01/29/2009 | WO2008115296A3 Modified phage for displaying post-translationally modified proteins and uses thereof |
| 01/29/2009 | US20090031455 Terpene hydroxylation |
| 01/29/2009 | US20090029459 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 01/29/2009 | US20090029441 assembling a plurality of rod-like viruses to form a wire-like structure such that a head of one rod-like virus is adjacent to a tail of an adjacent virus and polymerizing a plurality of monomers (having an thiol group) about the wire-like structure to fix the plurality of rod-like viruses together |
| 01/29/2009 | US20090029438 Composite materials comprising supported porous gels |
| 01/29/2009 | US20090029415 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof |
| 01/29/2009 | US20090029351 Method of measuring human cyp3a inducibility |
| 01/29/2009 | US20090028902 Viral particle comprising delipidated pestivirus viral particle: initiating a positive immune response in a patient; lower cholesterol content; reduced infectivity and enhanced antigenicity |
| 01/29/2009 | US20090028900 West nile viruses with mutations in the 3' terminal stem and loop secondary structure for use as live virus vaccines |
| 01/29/2009 | US20090028894 Papilloma Virus Capsomere Vaccine Formulations and Methods of Use |
| 01/29/2009 | US20090028890 encodes an HIV-1 MA polypeptide myristate binding site; capable of selectively eliciting a substantially th-1 immune response to HIV-1; vaccine |
| 01/29/2009 | CA2720570A1 Methods and compositions for live attenuated viruses |
| 01/29/2009 | CA2685308A1 Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles |
| 01/28/2009 | EP2019144A1 Vector particles for targeting CD34+ cells |
| 01/28/2009 | EP2019141A2 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 01/28/2009 | EP2019140A2 Attenuated human-bovine chimeric parainfluenza virus (PIV) vaccines |
| 01/28/2009 | EP2018421A2 Scalable production method for aav |
| 01/28/2009 | CN101355963A Marked bovine viral diarrhea virus vaccines |
| 01/28/2009 | CN101353670A Infectious bovine rhinotracheitis virus recombinant strain, construction method and use thereof |
| 01/28/2009 | CN101353667A HIV stain drug-resistant phenotype analytical cell model and special pseudotype lentivirus therefor |
| 01/28/2009 | CN101353666A HIV medicament screening cell model and special pseudotype lentivirus therefor |
| 01/28/2009 | CN101353663A Anti-I type diabetes fuse protein and preparation thereof |
| 01/28/2009 | CN101353647A Simulating retrovirus of target tumor, and preparation and use thereof |
| 01/28/2009 | CN101352570A Diploid cell rabies vaccine and method for preparing purified rabies vaccine |
| 01/27/2009 | US7482441 Artificial chromosomes comprising EHV sequences |
| 01/27/2009 | US7482156 Hepatocellular carcinoma specific promoter and uses thereof |
| 01/27/2009 | US7482150 Immunization against contagious and fatal hemorrhagic fever syndrome |
| 01/27/2009 | US7482149 Inhibition of SARS coronavirus infection with clinically approved antiviral drugs |
| 01/27/2009 | US7482115 Bacteriophage; antibiotics or bacteriostatic agents for treatment of antibiotic-resistant infections; medical equipment |